Results from two studies were presented at the 22nd European Society of Hypertension (ESH) in London highlighting the benefits of triple combination therapy for individuals suffering from hypertension. The results add to clinical understanding of olmesartan(O)/amlodipine(A)/hydrochlorothiazide(H) (O/A/H) triple combination therapy (Sevikar HCT®)... Via - http://www.medicalnewstoday.com/articles/244911.php
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন